CPT1A and neoplasm: CPT1A overexpression was also observed in CRC cells, and its inhibition by the treatment with a secolignan-type compound, 2,6-dihydroxypeperomin B (DHP-B), a compound isolated from the plant Peperomia dindygulensis, suppresses tumor growth and progression [112].